Amylyx Pharmaceuticals Inc (AMLX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amylyx Pharmaceuticals Inc   (NASDAQ: AMLX)


Amylyx Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amylyx Pharmaceuticals Inc's ROI in the second quarter of 2026?
Amylyx Pharmaceuticals Inc recorded a cumulative net loss of $-152 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -52.09%.

Within the Healthcare sector 479 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2202 to 3773.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 58.49 % 32.92 % 7.57 % -28.11 % -48.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 243 278 310 337 173
Return On Investment (TTM) -52.09 % -54.7 % -56.66 % -68.08 % -101.83 %
AMLX's Overall Ranking # 3773 # 2202 # 2673 # 3419 # 3305
Seq. Investment Change TTM 6.4 % 7.43 % 16.5 % 19.02 % -10.77 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -152 -150 -145 -149 -188

AMLX Company Profile >> Back to AMLX Roi Comparisons >> See Annual AMLX Return On Investment



Return On Investment AMLX's Ranking
Within: No.
Industry # 204
Sector # 480
Overall # 3773

Return On Investment Statistics
High Average Low
12.3 %
-59.07 %
-127.06 %
(Dec 31 2023)   (Dec 31 2024)







Financial Statements
Amylyx Pharmaceuticals Inc's II. Quarter Investments $ 243 Millions AMLX's Balance sheet
Amylyx Pharmaceuticals Inc's II. Quarter Income $ -43 Millions Quarterly AMLX's Income Statement
AMLX's Income by Division See AMLX's Income by Division


AMLX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022
Total Investments in Millions 310 165 435 345 0
Y / Y Investment Growth 87.59 % -62.05 % 26.26 % - -
Net Income in Millions -145 -302 49 -198 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -46.7 % -182.62 % 11.32 % -57.53 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMLX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMLX's Competitors
Subscribers only: Roi for Amylyx Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AMLX's Customers

Other Ratios
AMLX's Roa AMLX's Inventory Turnover Ratio AMLX's Growth Rates AMLX's Dividend Statistics
AMLX's Profitability Ratios AMLX's Asset Turnover Ratio AMLX's Dividend Growth
AMLX's Roe AMLX's Valuation Ratios AMLX's Financial Strength Ratios AMLX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:41:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.